Skip to content

Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Cord Injury

Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Cord Injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07368244
Enrollment
405
Registered
2026-01-26
Start date
2026-01-01
Completion date
2026-02-05
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries (SCI)

Keywords

InSCI, Nottwil Environmental Factors Inventory, NEFI, Turkish, cultural adaptation, content validity

Brief summary

This observational methodology study will produce a Turkish version of the Nottwil Environmental Factors Inventory (NEFI-TR) within one month using a standardized translation and cultural adaptation process. Content validity will be assessed using an expert panel (and, if applicable, cognitive debriefing with adults with spinal cord injury) to ensure relevance, clarity, and comprehensibility of each item in the Turkish context.

Detailed description

Translation/adaptation: (1) two independent forward translations into Turkish; (2) reconciliation and harmonization by a multidisciplinary committee; (3) back-translation by independent translators; (4) expert committee review for semantic, idiomatic, experiential, and conceptual equivalence; (5) pre-test/cognitive debriefing (if planned) and final revisions; (6) proofreading and finalization of NEFI-TR and documentation of all decisions.

Interventions

None listed

Sponsors

Istanbul Medeniyet University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (\>=16 years) with a diagnosis/history of spinal cord injury (traumatic or non-traumatic) * Living in Turkey * Able to read/understand Turkish and provide informed consent * Clinically stable to complete questionnaires

Exclusion criteria

* Fully recovered from SCI / no longer living with SCI-related functional consequences (as defined by your protocol) * Severe cognitive/communication limitations preventing valid completion * Any condition judged by investigators to preclude participation

Design outcomes

Primary

MeasureTime frameDescription
Item Content Validity Index (I-CVI)1 monthItem Content Validity Index (I-CVI) for NEFI-TR, derived from expert ratings of item relevance on a 4-point scale.
Scale Content Validity Index (S-CVI/Ave)1 monthScale Content Validity Index (S-CVI/Ave) for NEFI-TR, derived from expert ratings of item relevance on a 4-point scale.

Secondary

MeasureTime frameDescription
Qualitative feedback on clarity/comprehensibility1 monthQualitative feedback on clarity/comprehensibility; proportion of items requiring modification; (if cognitive debriefing) participant-rated clarity and acceptability.

Countries

Turkey (Türkiye)

Contacts

CONTACTBelgin Erhan, Prof
dr.belginerhan@gmail.com+905322678024

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026